15 terminated. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Terminated 15 |
Follow Leukemia: new trials by email Literature Review of Leukemia trials Research Report on Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase Levofloxacin, Placebo - Neutropenic Fever, Acute Lymphoblastic Leukemia | Phase 4 | Terminated | Gadjah Mada University | 49 | 2026-01-01 | 2026-10-01 |
| Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL Flumatinib, Imatinib - Acute Leukemia | Phase 4 | Terminated | Institute of Hematology & Blood Diseases Hospital, China | 39 | 2021-09-16 | 2025-05-01 |
| Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) Blinatumomab, Current Wearable Heatlth Monitoring System (CWHMS) - B-precursor Acute Lymphoblastic Leukemia | Phase 4 | Terminated | Amgen | 10 | 2021-08-26 | 2025-05-18 |
| N-Acetylcysteine vs Placebo as Adjunctive Treatment in Pediatric Leukemia N-Acetylcysteine, Placebo - Lymphoblastic Leukemia, Acute, Childhood | Phase 4 | Terminated | Teny Tjitra Sari | 16 | 2019-08-29 | 2022-11-09 |
| Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia Outpatient Care Model, CPX-351 - Leukemia, Myeloid, Acute | Phase 4 | Terminated | Medical College of Wisconsin | 3 | 2019-08-28 | 2022-07-19 |
| Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients Ketamine 100 MG/ML, Midazolam 5 MG/ML - Anxiety, Pediatric ALL | Phase 4 | Terminated | Brooke Army Medical Center | 10 | 2016-05-01 | 2023-04-25 |
| Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors Bosutinib - Previously Treated PH + CML | Phase 4 | Terminated | Pfizer | 163 | 2014-11-07 | 2021-12-30 |
| A Study to Evaluate Efficacy and Safety of Glinib in Newly Diagnosed CML Patients 600mg/day of Imatinib, 400mg/day of Imatinib - Chronic Myeloid Leukemia | Phase 4 | Terminated | Dong-A ST Co., Ltd. | 55 | 2014-10-13 | 2018-06-15 |
| Efficacy and Safety Assessment of NIlotinib in CML Patients With Suboptimal Response on Imatinib Therapy Nilotinib 300 mg. - Myeloid Leukemia, Chronic | Phase 4 | Terminated | King Abdullah International Medical Research Center | 98 | 2013-03-01 | 2017-03-07 |
| A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status Cyclophosphamide, Fludarabine, Rituximab - Lymphocytic Leukemia, Chronic | Phase 4 | Terminated | Hoffmann-La Roche | 89 | 2011-06-17 | 2018-03-20 |
| A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic Status Chlorambucil, Cyclophosphamide, Fludarabine - Lymphocytic Leukemia, Chronic | Phase 4 | Terminated | Hoffmann-La Roche | 26 | 2011-04-27 | 2019-03-14 |
| SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients filgrastim - Leukemia | Phase 4 | Terminated | Rabin Medical Center | 120 | 2011-01-01 | 2016-04-06 |
| Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations nilotinib - CML, Philadelphia Chromosome Positive (Ph+) | Phase 4 | Terminated | Novartis Pharmaceuticals | 3 | 2010-10-21 | 2021-05-20 |
| Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma PEG-interferon alfa-2b, Interferon alfa-2b, Valproic Acid - Lymphoma, Precancerous/Nonmalignant Condition | Phase 4 | Terminated | University of Miami | 13 | 2007-11-01 | 2018-04-17 |
| Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib bone marrow aspiration - Chronic Myeloid Leukemia, Gastrointestinal Stromal Cell Tumors | Phase 4 | Terminated | University Health Network, Toronto | 68 | 2005-02-01 | 2009-02-13 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (5) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (4) · Febrile Neutropenia (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Anxiety Disorders (1) · Bronchiolitis Obliterans Syndrome (1) · Chromosome Aberrations (1) · HTLV-I Infections (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myeloid, Chronic-Phase (1) · Lymphoma (1) · Neoplasm, Residual (1) · Precancerous Conditions (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (15) · Hemic and Lymphatic Diseases (15) · Neoplasms (15) · Neoplasms by Histologic Type (15) · Immune System Diseases (9) · Immunoproliferative Disorders (8) · Leukemia, Lymphoid (8) · Lymphatic Diseases (8) · Lymphoproliferative Disorders (8) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Chronic Disease (7) · Disease Attributes (7) · Leukemia, Myeloid (6)
Cyclophosphamide (2) · Imatinib Mesylate (2) · Rituximab (2) · fludarabine (2) · nilotinib (2) · Acetylcysteine (1) · CPX-351 (1) · Chlorambucil (1) · Cytarabine (1) · Filgrastim (1) · Interferon alpha-2 (1) · Ketamine (1) · Levofloxacin (1) · Midazolam (1) · Valproic Acid (1)
Hoffmann-La Roche (2) · Amgen (1) · Brooke Army Medical Center (1) · Dong-A ST Co., Ltd. (1) · Gadjah Mada University (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · King Abdullah International Medical Research Center (1) · Medical College of Wisconsin (1) · Novartis Pharmaceuticals (1) · Pfizer (1) · Rabin Medical Center (1) · Teny Tjitra Sari (1) · University Health Network, Toronto (1) · University of Miami (1)
United States (6) · Indonesia (2) · Russia (2) · Austria (1) · Canada (1) · China (1) · France (1) · Germany (1) · Israel (1) · Italy (1) · Norway (1) · Saudi Arabia (1) · South Korea (1) · Spain (1) · Sweden (1)
Chul-won Choi, M.D. (1) · Chul-won Jung, M.D. (1) · Dr. Ahmad S. Alaskar, MD,FACP,FRCP (1) · Duk-yeon Cho, M.D. (1) · Idha Yulandari, M.D. Pediatric (1) · Jeff Lipton, MD (1) · Jin-hee Park, M.D. (1) · Joo-sup Joeng, M.D. (1) · Joon-sung Park, M.D. (1) · Juan Carlos Ramos, MD (1) · Jung-ok Lee, M.D. (1) · Kyu-Hyoung Lee, M.D. (1) · Kyung-ha Kim, M.D. (1) · Laura Michaelis, MD (1)
PMID 30208456, PMID 32572189, PMID 33041718, PMID 35235189, PMID 38007586, PMID 38484432, PMID 39164407
P01CA128115 (1)